The efficacy of oral treatment with chewable tablets containing afoxolaner 2.27% w/w (NexGard?, Merial, now part of Boehringer-Ingelheim) or 1.875% w/w of afoxolaner and 0.375% w/w milbemycin oxime (NexGard Spectra?, ...
Supported by National Science and Technology Development Agency(Thailand)for a Research Chair Grant
AIM: To determine the prevalence of ocular demodicosis by both microscopic examination and molecular detection among patients at King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok.METHODS: One hun...